Stock 002653 HAISCO PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
30.36 CNY +1.47% Intraday chart for Haisco Pharmaceutical Group Co., Ltd. +15.00% +31.14%
Apr. 19 Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 18 Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules
MT
Haisco Pharma Gets Nod to Trial Asthma Drug
MT
Haisco Pharma Gets Nod to Trial HSK16149 Capsule as Central Neuropathic Pain Drug
MT
Haisco Pharma's Unit Gets Nod to Trial Drug for Hemolytic Diseases
MT
Haisco Pharma's Unit Gets Nod to Trial Tumor Drug Candidate
MT
Haisco Pharma to Set Up New Subsidiary in China’s Tibet Region
MT
Haisco Pharmaceutical Signs $462 Million Deal with Italy’s Chiesi Farmaceutici
MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes
CI
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Haisco Pharmaceutical's Unit Gets Greenlight to Trial Diabetes Drug
MT
Haisco Pharma's Rupatadine Fumarate Tablets Passes Regulator's Evaluation
MT
Haisco Pharma’s Blood Clot Drug Passes Generic Consistency Evaluation in China
MT
Haisco Pharma Unit Gets Certification for Formula Food
MT
Haisco Pharma Gets Nod for HSK31679 Tablet Trial
MT
Haisco Pharma Unit Registers Nutritional Formula Food
MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Haisco Pharma Unit Gets Certificate for Two Food Supplements
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. News Haisco Pharmaceutical Group Co., Ltd.